PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Seattle Cancer Care Alliance, Seattle, WA.\', \'Division of Hematology, Department of Medicine, University of Washington, Seattle, WA.\', \'Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.\', \'Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.\', \'Department of Radiation Oncology, University of Washington, Seattle, WA.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1200/OP.20.00241
?:hasPublicationType
?:journal
  • JCO oncology practice
is ?:pmid of
?:pmid
?:pmid
  • 32369409
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32369409>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32369409>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all